Free Trial
CVE:GRN

Greenlane Renewables Inc. (GRN.V) (GRN) Stock Price, News & Analysis

Greenlane Renewables Inc. (GRN.V) logo
C$2.78 +0.39 (+16.32%)
As of 02/16/2021

About Greenlane Renewables Inc. (GRN.V) Stock (CVE:GRN)

Key Stats

Today's Range
C$2.49
C$2.80
50-Day Range
C$2.78
C$2.78
52-Week Range
C$0.19
C$2.90
Volume
3.04 million shs
Average Volume
1.68 million shs
Market Capitalization
C$368.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
C$0.05
Consensus Rating
Sell

Company Overview

Greenlane Renewables Inc. provides biogas upgrading systems worldwide. The company's systems remove impurities and separate carbon dioxide from biomethane in the raw biogas created from anaerobic decomposition of organic waste at landfills, wastewater treatment plants, and farms and food waste facilities for injection into the natural gas grid or for direct use as vehicle fuel. It offers water wash, pressure swing adsorption, and membrane separation technologies. The company markets and sells its upgrading systems under the Greenlane Biogas brand. The company was formerly known as Creation Capital Corp. and changed its name to Greenlane Renewables Inc. in June 2019. Greenlane Renewables Inc. was incorporated in 2018 and is headquartered in Burnaby, Canada.

Receive GRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Greenlane Renewables Inc. (GRN.V) and its competitors with MarketBeat's FREE daily newsletter.

GRN Stock News Headlines

Greenlane Renewables Inc Ordinary Shares GRN
Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
See More Headlines

GRN Stock Analysis - Frequently Asked Questions

Greenlane Renewables Inc. (GRN.V)'s stock was trading at C$2.78 at the beginning of 2025. Since then, GRN shares have increased by 0.0% and is now trading at C$2.78.
View the best growth stocks for 2025 here
.

Shares of GRN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Greenlane Renewables Inc. (GRN.V) investors own include Abbott Laboratories (ABT), Xebec Adsorption Inc. (XBC.V) (XBC.V), NIO (NIO), Enbridge (ENB), good natured Products (GDNP), TJX Companies (TJX).

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Pollution & Treatment Controls
Sub-Industry
Banking
Current Symbol
CVE:GRN
CIK
N/A
Fax
N/A
Employees
49
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
C$0.05
High Stock Price Target
C$0.05
Low Stock Price Target
C$0.05
Potential Upside/Downside
-98.2%
Consensus Rating
Sell
Rating Score (0-4)
1.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
139.00
P/E Growth
-7666.67
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$16.93 million
Cash Flow
C$0.07 per share
Price / Cash Flow
40.86
Book Value
C$0.19 per share
Price / Book
14.79

Miscellaneous

Free Float
N/A
Market Cap
C$368.17 million
Optionable
Not Optionable
Beta
N/A
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (CVE:GRN) was last updated on 5/15/2025 by MarketBeat.com Staff
From Our Partners